SXT / TRY

SXT / USDT

SXT / USDC

ROSE / BTC

ROSE / USDT

ROSE / USDC

ROSE / TRY

AXS / TRY

AXS / USDC

AXS / USDT

FRAX / USDT

FIDA / BTC

FIDA / TRY

FIDA / USDT

SHELL / TRY

SHELL / USDT

SHELL / USDC

PHA / USDC

PHA / TRY

PHA / USDT

ADITYBIRLA SL GOLD ETF-GR

INSPIRE FILMS LIMITED

ALMONDZ GLOBAL SEC LTD

KANPUR PLASTIPACK LIMITED

GLOBAL PET INDUSTRIES LTD

AXIS MF - AXIS GOLD ETF

PICCADILY AGRO INDUSTRI L

INVESCO INDIA GOLD ETF

SILGO RETAIL LTD

VMS TMT LIMITED

OMFURN INDIA LIMITED

KALYAN JEWELLERS IND LTD

AKSH OPTIFIBRE LIMITED

FINKURVE FINANCIAL SERV L

SHIGAN QUANTUM TECH LTD

HAPPY SQUARE OUTSOURC S L

VIP CLOTHING LIMITED

SATI POLY PLAST LIMITED

ZENITH STEEL PIP IND LTD

R. S. SOFTWARE (INDIA) LI

Click here to get full coverage on Indoco Remedies Schedules Earnings Call for Q3 and Nine-Month FY26 Results - TipRanks

Indoco Remedies Schedules Earnings Call for Q3 and Nine-Month FY26 Results  TipRanks

Indoco Remedies Schedules Earnings Call for Q3 and Nine-Month FY26 Results - TipRanks

Click here to get full coverage on Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely  simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Click here to get full coverage on Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva  Yahoo Finance

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Click here to get full coverage on Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga - Indian Pharma Post

Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga  Indian Pharma Post

Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga - Indian Pharma Post

Click here to get full coverage on Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban  Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Click here to get full coverage on Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12% - CNBC TV18

Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12%  CNBC TV18

Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12% - CNBC TV18

Click here to get full coverage on Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains  Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Click here to get full coverage on Indoco Remedies Gains USFDA Approval for Allopurinol Tablets USP 200 mg to Address Hyperuricemia - geneonline.com

Indoco Remedies Gains USFDA Approval for Allopurinol Tablets USP 200 mg to Address Hyperuricemia  geneonline.com

Indoco Remedies Gains USFDA Approval for Allopurinol Tablets USP 200 mg to Address Hyperuricemia - geneonline.com

Click here to get full coverage on Indoco Remedies Q2 Review — Dolat Capital Hikes Target Price Maintaining ‘Sell’, Sees 15% Downside - NDTV Profit

Indoco Remedies Q2 Review — Dolat Capital Hikes Target Price Maintaining ‘Sell’, Sees 15% Downside  NDTV Profit

Indoco Remedies Q2 Review — Dolat Capital Hikes Target Price Maintaining ‘Sell’, Sees 15% Downside - NDTV Profit

Click here to get full coverage on Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh - HDFC Sky

Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh  HDFC Sky

Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh - HDFC Sky

Click here to get full coverage on Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg  Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Click here to get full coverage on Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit - Business Standard

Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit  Business Standard

Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit - Business Standard

Click here to get full coverage on Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition - scanx.trade

Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition  scanx.trade

Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition - scanx.trade

Click here to get full coverage on Indoco Remedies subsidiary launches generic drug in UK - ET Pharma

Indoco Remedies subsidiary launches generic drug in UK  ET Pharma

Indoco Remedies subsidiary launches generic drug in UK - ET Pharma

Click here to get full coverage on Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259  simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Click here to get full coverage on Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood  Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Click here to get full coverage on Indoco Remedies Ltd Faces Intensified Bearish Momentum Amid Technical Downgrade - Markets Mojo

Indoco Remedies Ltd Faces Intensified Bearish Momentum Amid Technical Downgrade  Markets Mojo

Indoco Remedies Ltd Faces Intensified Bearish Momentum Amid Technical Downgrade - Markets Mojo

Click here to get full coverage on USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility  Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Technical Momentum Shifts Amid Market Challenges - Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Market Challenges  Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Market Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies Ltd is Rated Strong Sell - Markets Mojo

Indoco Remedies Ltd is Rated Strong Sell  Markets Mojo

Indoco Remedies Ltd is Rated Strong Sell - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance - Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance  Markets Mojo

Indoco Remedies Faces Mixed Technical Trends Amid Market Volatility and Underperformance - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Challenging Market Assessment Amidst Financial and Technical Shifts - Markets Mojo

Indoco Remedies Faces Challenging Market Assessment Amidst Financial and Technical Shifts  Markets Mojo

Indoco Remedies Faces Challenging Market Assessment Amidst Financial and Technical Shifts - Markets Mojo

Click here to get full coverage on Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility  Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Technical Momentum Shifts Amid Bearish Market Signals - Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Bearish Market Signals  Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Bearish Market Signals - Markets Mojo

Click here to get full coverage on Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa  Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Click here to get full coverage on Indoco Remedies Receives USFDA EIR for API Manufacturing Facility at Patalganga - scanx.trade

Indoco Remedies Receives USFDA EIR for API Manufacturing Facility at Patalganga  scanx.trade

Indoco Remedies Receives USFDA EIR for API Manufacturing Facility at Patalganga - scanx.trade

Click here to get full coverage on Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges - Markets Mojo

Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges  Markets Mojo

Indoco Remedies Experiences Technical Shift Amid Ongoing Financial Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies gets USFDA EIR for Patalganga facility - Medical Dialogues

Indoco Remedies gets USFDA EIR for Patalganga facility  Medical Dialogues

Indoco Remedies gets USFDA EIR for Patalganga facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show  Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Click here to get full coverage on Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA  Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Click here to get full coverage on What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside  Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

Click here to get full coverage on Indoco Remedies Technical Momentum Shifts Amid Bearish Signals - Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Bearish Signals  Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Bearish Signals - Markets Mojo

Click here to get full coverage on Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance - Markets Mojo

Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance  Markets Mojo

Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance - Markets Mojo

Click here to get full coverage on Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO - scanx.trade

Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO  scanx.trade

Indoco Remedies Enters ₹24.65 Crore Sale-Leaseback Deal for Waluj Facility and CRO - scanx.trade

Click here to get full coverage on Indoco Remedies Shares Rally 4% on Securing EIR from USFDA - Equitypandit

Indoco Remedies Shares Rally 4% on Securing EIR from USFDA  Equitypandit

Indoco Remedies Shares Rally 4% on Securing EIR from USFDA - Equitypandit

Click here to get full coverage on Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate  CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Click here to get full coverage on Indoco Remedies Reports 9% Revenue Growth in Q2, Despite Challenges - scanx.trade

Indoco Remedies Reports 9% Revenue Growth in Q2, Despite Challenges  scanx.trade

Indoco Remedies Reports 9% Revenue Growth in Q2, Despite Challenges - scanx.trade

Click here to get full coverage on 'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside - Here's Why - NDTV Profit

'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside - Here's Why  NDTV Profit

'Sell' Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside - Here's Why - NDTV Profit

Click here to get full coverage on Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability - Markets Mojo

Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability  Markets Mojo

Indoco Remedies Faces Technical Shift Amid Ongoing Financial Challenges and Declining Profitability - Markets Mojo

Click here to get full coverage on Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts  CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Click here to get full coverage on Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK - Medical Dialogues

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK  Medical Dialogues

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK - Medical Dialogues

Click here to get full coverage on Indoco Remedies Technical Momentum Shifts Amid Challenging Market Returns - Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Challenging Market Returns  Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Challenging Market Returns - Markets Mojo

Click here to get full coverage on Indoco Remedies Forms Death Cross, Signalling Potential Bearish Trend - Markets Mojo

Indoco Remedies Forms Death Cross, Signalling Potential Bearish Trend  Markets Mojo

Indoco Remedies Forms Death Cross, Signalling Potential Bearish Trend - Markets Mojo

Click here to get full coverage on Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Indoco Remedies enters into sale and lease back for its movable properties  Business Standard

Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Click here to get full coverage on Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent - Social Samosa

Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent  Social Samosa

Initiative secures media mandate for Indoco Remedies’ oral care brand Sensodent - Social Samosa

Click here to get full coverage on Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg - Express Pharma

Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg  Express Pharma

Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg - Express Pharma

Click here to get full coverage on Indoco Remedies: President - Sales & Marketing Ajay Karajagi to retire - Medical Dialogues

Indoco Remedies: President - Sales & Marketing Ajay Karajagi to retire  Medical Dialogues

Indoco Remedies: President - Sales & Marketing Ajay Karajagi to retire - Medical Dialogues

Click here to get full coverage on Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II  Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Click here to get full coverage on Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher - Moneycontrol

Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher  Moneycontrol

Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher - Moneycontrol

Click here to get full coverage on Indoco Remedies Reports Stable Sales Amid Rising Financial Pressures and Market Struggles - Markets Mojo

Indoco Remedies Reports Stable Sales Amid Rising Financial Pressures and Market Struggles  Markets Mojo

Indoco Remedies Reports Stable Sales Amid Rising Financial Pressures and Market Struggles - Markets Mojo

Click here to get full coverage on Indoco Remedies Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Mixed Market Signals  Markets Mojo

Indoco Remedies Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Click here to get full coverage on Indoco Remedies Posts ₹40.4 Crore Net Loss in Q4 FY25 - India Infoline

Indoco Remedies Posts ₹40.4 Crore Net Loss in Q4 FY25  India Infoline

Indoco Remedies Posts ₹40.4 Crore Net Loss in Q4 FY25 - India Infoline

Click here to get full coverage on Indoco launches Ticagrelor film-coated tablets 90mg in the UK market - Express Pharma

Indoco launches Ticagrelor film-coated tablets 90mg in the UK market  Express Pharma

Indoco launches Ticagrelor film-coated tablets 90mg in the UK market - Express Pharma

Click here to get full coverage on Indoco Remedies Sees Revision in Market Evaluation Amidst Challenging Financials - Markets Mojo

Indoco Remedies Sees Revision in Market Evaluation Amidst Challenging Financials  Markets Mojo

INDOCO

Price Chart

Key Statistics

Technicals

About INDOCO

Latest News

Indoco Remedies Schedules Earnings Call for Q3 and Nine-Month FY26 Results - TipRanks

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers